Dopamine rushes, withdrawals, and detoxes are trending among wellness gurus online. But experts say the science behind the ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Dr. Raheja has expanded psychiatric care through telepsychiatry, bringing services to rural Wisconsin at Thedacare Regional ...
A large (n = 3,070) 52-week, randomized, placebo-controlled (2:1), double-blind trial evaluated overall and cardiovascular safety of Cycloset in type 2 diabetic patients treated with diet alone ...
Hosted on MSN22d
Dopamine acts on motivation and reinforcement learning via distinct cellular processes, study suggestsTheir findings, published in Nature Neuroscience, suggest that different aspects of reward-related behavior are supported by two distinct dopamine receptors, namely D3 and D1. "The previous ...
The US Food and Drug Administration (FDA) has approved Supernus Pharmaceuticals’ Onapgo (apomorphine hydrochloride) injection ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback